论文信息 - Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2–Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor - 字舞流文

Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2–Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor

S. Chandarlapaty | J. Baselga | H. Gómez | N. Rosen | C. Geyer | M. Koehler | D. Cameron | J. Arribas | M. Scaltriti | C. Aura | L. Prudkin | R. Gagnon | P. Angelini | C. Ellis | J. Jiménez | J. Parra | M. Guzman | Gertrudis Sánchez